Association of diabetes type 2 and depression - Behavioural and biological aspects;Assoziation von Diabetes Typ 2 und Depressivität: Verhaltenspsychologische und biologische Aspekte

Deutsche Medizinische Wochenschrift

Volumn 139, Issue 8, 2014, Pages 369-374

  Wagner, G ^a   Icks, A ^b,c   Redaelli, M ^a,d   Albers, B ^c   Abholz, H H ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b Department of Orthopedic Surgery   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

behaviour related risk factors; depression; pathophysiology risk factors; type 2 diabetes

Indexed keywords

ANTIDEPRESSIVE AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; CYTOKINES; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; HEALTH BEHAVIOR; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN-SECRETING CELLS; LIFE STYLE; OXIDATIVE STRESS; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84893968492     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0033-1360066     Document Type: Article

References (77)

1. Ajilore O., Haroon E., Kumaran S. et al. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropharmacology: 2007; 32 1124 1231
2. Andersohn F., Schade R., Suissa S. et al. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry: 2009; 166 591 598
3. Atlantis E., Browning C., Sims J. et al. Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). Int J Geriatr Psychiatry: 2009; 25 688 696
4. Barzilay J. I., Abraham I., Heckbert S. R. et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes: 2001; 50 2384 2389 (Pubitemid 33641926)
5. Bisshop M. I., Kriegman D. M., Deeg D. J. et al. The longitudinal relation between chronic diseases and depression in older persons in the community: the Longitudinal Aging Study Amsterdam. J Clin Epidemiol: 2004; 57 187 194 (Pubitemid 38668613)
6. Björntorp P., Holm G., Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabetic Medicine: 1999; 16 373 383
7. Brown L., Majumdar S. R., Johnson J. A. Type of antidepressant therapy and risk of type 2 diabetes in people with diabetes. Diabetes Res Clin Pract: 2008; 79 61 67
8. Cameron O., Thomas B., Tiongeo D. et al. Hypercortisolism in diabetes mellitus. Diabetes Care: 1987; 10 662
9. Capuron L., Ravaud A., Neveu P. J. et al. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Molecular Psychiatry: 2002; 7 468 473 (Pubitemid 34712898)
10. Carney R. M., Freedland K. E., Veith R. C. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med: 2005; 67 29 S33
11. Carroll D., Phillips A. C., Hunt K. et al. Symptoms of depression and cardiovascular reactions to acute psychological stress: evidence from a population study. Biological Psychiatry: 2007; 75 68 74 (Pubitemid 46400971)
12. Champaneri S., Wand G. S., Malhotra S. S. et al. Biological basis of depression in adults with diabetes. Curr Diab Rep: 2010; 396 405
13. Chiodini I., Adda G., Scillitani A. et al. Cortisol secretion in patients with type 2 diabetes. Diabetes Care: 2007; 30 83 88
14. Cummings J. L. Frontal-subcortical circuits and human behavior. Arch Neurol: 1993; 50 873 80 (Pubitemid 23229317)
15. De Groot M., Anderson R., Freedland K. et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med: 2001; 63 619 630 (Pubitemid 32695143)
16. Engum A., Mykletun A., Midthjiell K. et al. Depression and diabetes: a large population based study of sociodemographic, lifestyle, and clinical factors associated with type 1 and type 2 diabetes. Diabetes Care: 2005; 28 1904 1909 (Pubitemid 41060961)
17. Festa A., DAgostino R., Tracey P. R. et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes: 2002; 51 1131 1137 (Pubitemid 34438360)
18. Golden S. H. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diab Rev: 2007; 3 252 259 (Pubitemid 350111108)
19. Golden S. H., Lazo M., Carnethon M. et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA: 2008; 299 2751 2759 (Pubitemid 351846850)
20. Goodnick P. J. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry: 2001; 13 31 41 (Pubitemid 32660581)
21. Grassi G., Quarti-Trevano F., Seravalle G. et al. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutrition, Metabolism and Cardiovascular Disease: 2007; 17 473 481 (Pubitemid 47082427)
22. Harvey B. H., Bouwer C. D. Neuropharmacology of paradoxic weight gain with selective reuptake inhibitors. Clin Neuropharmacol: 2000; 23 90 97 (Pubitemid 30212219)
23. Hennings J. M., Owashi T., Binder E. B. et al. Clinial characteristics and treatment outcome in a representative sample of depressed inpatients-findings from the Munic Antidepressant Response Signature (MARS) project. J Psychiatr Res: 2009; 43 215 229
24. Hirschfeld R. MA. Long-term side effects of SSRIs: sexual dysfunction and weight gain. J Clin Psychiatry: 2003; 64 18 20 24
25. Holsboer F. Stress, hypercortisolism and corticoid receptors in depression: implications for therapy. J Affect Disord: 2001; 62 77 91 (Pubitemid 32126613)
26. Hudson J., Hudson M. S., Rothschild A. J. et al. Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Arch Gen Psychiatry: 1984; 41 1086 1089 (Pubitemid 14017421)
27. Kaneto H., Katakami N., Matsuhisa M. et al. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators of Inflammation: 2010; 10.1155/2010/453892
28. Katon W. J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry: 2003; 54 216 226 (Pubitemid 37270614)
29. Kemp A. H., Quintana D. S., Gray M. A. et al. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry: 2010; 67 1067 1074
30. Kent S., Bluthe R. M., Kelley K. W. et al. Sickness behavior as a new target for drug development. Trends in Pharmacological Science: 1992; 13 24 28
31. Kern P. A., Saghizadeh M., Ong J. M. et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoptotein lipase. J Clin Invest: 1995; 95 2111 2119
32. Khoza S., Barner J. C., Bohmann T. M. et al. Use of antidepressant agents and the risk of type 2 diabetes. Eur J Clin Pharmacol: 2012; 68 1295 1302
33. Kivimäki M., Hamer M., Batty G. D. et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes. Diabetes Care: 2010; 33 2611 2616
34. Knol M. J., Geeling M. I., Egberts A. C. et al. No increased incidence of diabetes in antidepressant users. International Journal of Clinical Psychopharmacology: 2007; 22 282 286
35. Krabbe K. S., Nielsen A. R., Krogh-Madsen R. et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia: 2007; 50 431 438
36. Kumar A., Gupta R., Thomas A. et al. Focal subcortical biophysical abnormalities in patients diagnosed with type 2 diabetes and depression. Arch Gen Psychiatry: 2009; 66 324 330
37. Laske C., Eschweiler G. Brain-derived neurotrophic factor. Der Nervenarzt: 2006; 77 523 537
38. Licht C. M., de Geus E. J., Zitman F. G. et al. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry: 2008; 65 1358 1367
39. Lustman P. J., Griffith L. S., Clouse R. E. et al. Effects of nortriptyline on depression and glycemic control in diabetes: results from a double-blind placebo-controlled trial. Psychosom Med: 1997; 59 241 250 (Pubitemid 27240725)
40. Lysy Z., Da Costa D., Dasgupta K. The association of physical activity and depression in Type 2 diabetes. Diabetic Medicine: 2008; 25 1133 1141
41. Maes M. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuropsychopharmacol Biol Psychiatry: 2011; 35 784 794
42. Maes M., Kubera M., Obuchowiczwa E. et al. Depression's multiple comobidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett: 2011; 32 7 24
43. McIntyre R. S., Soczynska J. K., Konarski J. Z. et al. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf: 2006; 5 157 168 (Pubitemid 43056447)
44. Mezuk B., Eaton W. W., Albrecht S. et al. Depression and type 2 diabetes over a lifespan: a meta-analysis. Diabetes Care: 2008; 31 2383 2391
45. Musselman D. L., Betan E., Larsen H. et al. Relationship of depression to diabetes type 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry: 2003; 54 317 329 (Pubitemid 37267861)
46. Pan A., Sun Q., Okerke O. I. et al. Use of antidepressant medication and the risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia: 2012; 55 63 72
47. Penninx B. WJH, Milaneschi Y., Lamers F. et al. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med: 2013; 11 129 143
48. Pertsov S. S., Balashova T. S., Kubatieva A. A. et al. Lipid peroxidation and antioxidant enzymes in rat brain in acute emotional stress: effect of interleukin-1beta. Bull Exp Biol Med: 1995; 120 244 247
49. Pickup J. C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care: 2004; 27 813 823 (Pubitemid 38280558)
50. Polsky D., Doshi J. A., Marcus S. et al. Long-term risk of depressive symptoms after a medical diagnosis. Arch Intern Med: 2005; 165 1260 1266 (Pubitemid 40989590)
51. Pradhan A. D., Manson J. E., Rifai N. et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA: 2001; 286 327 334 (Pubitemid 32656163)
52. Prestle S., Aldenhoff J., Reiff J. Die HPA-Achse als mögliches Bindeglied zwischen Depression und Diabetes mellitus und kognitiven Störungen. Fortschr Neurol Psychiatr: 2003; 71 24 36 (Pubitemid 36206950)
53. Purnell J. Q., Kahn S. E., Samuels M. H. et al. Enhanced cortisol production rate, free cortisol, and 11 beta HSD 1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab: 2009; 296 E351 E357
54. Raadsher F. C., Hoogendijk W. J., Stam F. C. et al. Increased numbers of corticotropin -releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology: 1994; 60 436 443
55. Raison C. L., Demetrashvili M., Capuron L. et al. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs: 2005; 19 105 123 (Pubitemid 40321763)
56. Rao U., Poland R. E. Electroencephalographic sleep and hypothalamic -pituitary-adrenal changes from episode in recovery in depressed adolescents. J Child Adolesc Psychopharmacol: 2009; 34 1936 1945
57. Regen F., Merkl A., Heuser I. et al. Diabetes und Depression. Dtsch med Wochenschr: 2005; 130 1097 1102 (Pubitemid 40796120)
58. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med: 1999; 340 115 126
59. Rottenberg J. Cardiac vagal control in depression: a critical analysis. Biological Psychology: 2007; 74 200 211 (Pubitemid 44969448)
60. Roy M., Collier B., Roy A. Hypothalamic-pituary-adrenal axis dysregulation among diabetic outpatients. Psychiatry Research: 1989; 31 31 37
61. Rubin R. R., Yong M. A., Marrero D. G. et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the Diabetes Prevention program. Diabetes Care: 2008; 31 420 427
62. Rubin R. R. Comorbid Depression and Diabetes. Natural history and clinical aspects. In: LeRoith D., Vinik A. I. Contemporary Endocrinology: Controversies in treating diabetes: Clinical and research aspects. Totowa, NJ Humana Press: 2008
63. Rustad J. K., Musselman D. L., Nemeroff C. B. The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology: 2011; 36 1276 1286
64. Saghizadeh M., Ong J. M., Garvey W. T. et al. The expression of THF-α by human muscle. Relationship to insulin resistance. J Clin Invest: 1996; 97 1111 1116 (Pubitemid 26070591)
65. Sambamoorthi U., Ma Y., Findley P. A. et al. Antidepressant use, depression, and new onset diabetes among elderly Medicaire Beneficiaries. J Diabetes 10.1111/1753-0407.12014
66. Schmidt M. I., Duncan B. B., Sharrett A. R. et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet: 1999; 353 1649 1652 (Pubitemid 29224520)
67. Shelton R. C., Miller A. H. Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol: 2010; 91 275 299
68. Skala J. A. Hypothesis 5: Treatment of depression may reduce the risk of diabetes and its complications. Diabetes Spectrum: 2004; 17 158 159
69. Sosnovskii A. S., Kozlov A. V. Increased lipid peroxidation in the rat hypothalamus after short-term emotional stress. Bull Exp Biol Med: 1992; 113 486 488
70. Stein P. K., Barzilay J. L., Domitrovich P. P. et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome. The Cardiovascular Health Study. Diabetic Medicine: 2007; 24 855 863 (Pubitemid 47093043)
71. Sternberg E. M. The stress response and the regulation of inflammatory disease. Ann Intern Med: 1992; 117 854 866
72. Stetler C., Miller G. E. Depression and hypothalamic-pituary-adrenal activation. Summary of four decades of research. Psychosom Med: 2011; 73 114 126
73. Stuart M. J., Baune B. T. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidtity. Neurosci Biobehav Rev: 2012; 36 658 676
74. Taylor C. B., Conrad A., Wilhelm F. H. et al. Psycho-physiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated cardiovascular disease risk. Psychosom Med: 2006; 68 538 546 (Pubitemid 44297649)
75. Tyler W. J., Alonso M., Bramham C. R. et al. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem: 2002; 9 224 237
76. Wagner G., Icks A., Albers B. et al. Typ 2 Diabetes mellitus und Depressivität: was ist ursächlich für was? Eine systematische Literaturübersicht. Dtsch med Wochenschr: 2012; 137 523 528
77. Wang X., Bao W., Liu J. et al. Inflammatory markers and risk of type 2 diabetes. A systematic review and meta-analysis. Diabetes Care: 2013; 36 166 175